Skip to content
Search

Latest Stories

'Scrap VAT rate applied to sunscreen products'

Co-op Midcounties has urged the government to exempt sunscreen products from value added tax (VAT).

The consumer co-operative has written to the government to reclassify sunscreen as an essential healthcare item, which would allow it to be VAT exempt.


The average bottle of sunscreen costs between £5 and £7, with around £1.50 VAT charge.

Sunscreen is currently classified in the UK as a “cosmetic product”. However, Cancer Research UK has found that getting sunburnt just once every two years can triple the risk of melanoma skin cancer.

The melanoma skin cancer incidence rates have more than doubled (135 per cent) in the UK since the early 1990s.

Co-op Midcounties Chief Executive Phil Ponsonby said: “Sunscreen is an essential healthcare product and we don’t think it’s right or fair that it should incur VAT. We need to do everything we can to make it as affordable as possible, and we’re therefore asking people to join our campaign, write to their MP and make a change that will help to reduce the risk of skin cancer for everyone.”

Co-op Midcounties expects removing VAT from these essential items will play a significant part in making sunscreen more affordable.

Dr Jones said: “Sunscreen is a really important medical product that prevents against the risk of skin cancer. I fully support the Co-op Midcounties campaign and it’s important that we get Ministers interested in removing VAT from sunscreen. There is a wide consensus of doctors, skin specialists, dermatologists and cancer specialists who would agree that sunscreen should be reclassified as a healthcare product.”

More For You

GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less
Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
CPCF negotiations: CPE working to secure the best outcomes for the sector
Pharmacy sector demands urgent resolution of CPCF negotiations (gettyimages)

CPCF Negotiations: CPE unable to share details until official announcement

Acknowledging the sector's urgent need to resolve CPCF negotiations, CPE reiterates its commitment to securing the best possible outcome

Community Pharmacy England (CPE) has provided an update on the ongoing 2024/25 and 2025/26 Community Pharmacy Contractual Framework (CPCF) negotiations with the Department of Health and Social Care (DHSC) and NHS England.

“The Negotiating Team are continuing in-depth negotiations with DHSC and NHS England,” the Committee said, adding that they are focused on securing the “best outcomes” for pharmacy owners.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less